-
Jefferies Ups EW To Buy
Monday, April 4, 2011 - 6:33am | 51Analysts at Jefferies upgrade Edwards Lifesciences Corp (NYSE: EW) from “hold” to “buy.” The target price for EW has been raised from $93 to $103. EW shares fell 1.07% to close at $86.07 on Friday. More Analyst Ratings here
-
The Canary Chirped
Friday, April 1, 2011 - 5:52pm | 887Cusick's Corner The market held its ground into the After Hours, but I did not see the thrust that I would give the bulls the total edge. Next week has the potential to be more volatile, with the EU rate decisions on the Thursday, looks like more tightening by the hawks looming, and the canary,...
-
Medtronic Announces FDA Approval of InterStim Therapy for Bowel Control
Friday, April 1, 2011 - 4:04pm | 100Medtronic, Inc. (NYSE: MDT) today announced U.S. Food and Drug Administration (FDA) approval of InterStim Therapy for Bowel Control. InterStim Therapy, previously available to treat the symptoms of overactive bladder and non-obstructive urinary retention, is now also approved for the treatment of...
-
Puts Purchased on Boston Scientific Corporation (BSX)
Friday, April 1, 2011 - 11:09am | 151Shares of Boston Scientific Corporation (NYSE: BSX) are higher on the session by 4.17%, currently trading at $7.49. The stock has been moving largely higher over the past six months and is currently trading above the 50-day and 200-day moving averages. Options traders are buying puts on the name...
-
Active Screen - CANSLIM: Top 8 for April 1st
Friday, April 1, 2011 - 10:17am | 1006For this week the Top-8 as ranked by Market Cap are Apple (AAPL), Vale S.A. (VALE), Free McMoran (FCX), Barrick Gold (ABX), Baidu (BIDU), Research in Motion (RIMM), Cognizant Technlogy (CTSH), and Intuitive Surgical (ISRG). The Screener setup was as follows: Apple (AAPL) continues to hold the 50-...
-
Morgan Stanley Highlights From COV Analyst Day
Friday, April 1, 2011 - 8:30am | 202Morgan Stanley is providing some highlights from Covidien's (NYSE: COV) analyst day. “Covidien surprises in surgical dissection and sealing,” Morgan Stanley writes. “Further insights from SAGES are forthcoming but we wanted to highlight two points from Covidien's analyst day. “While we expected...
-
HSP's 1Q11 IMS Sales Are Improving, Morgan Stanley Reports
Friday, April 1, 2011 - 8:08am | 901Q11 IMS sales are improving for Hospira Inc. (NYSE: HSP), Morgan Stanley reports. “On a reported basis, total Hospira IMS sales were down 4% y/y QTD 1Q11m,” Morgan Stanley writes. “However, sales were up 23% y/y and 16% vs 4Q10 (excluding oxaliplatin) with recent launches (Zosyn and gemcitabine)...
-
J.P. Morgan Reiterates Overweight Rating On Covidien
Friday, April 1, 2011 - 8:03am | 74According to J.P. Morgan, Covidien (NYSE: COV) Overweight rating is reiterated. J.P. Morgan reported that the 2011 SAGES meeting is underway in San Antonio. “In the Endo-Mechanical markets, J&J has stolen the headlines at this year's meeting, introducing the first power stapler, while Covidien...
-
Piper Jaffray Updates From SAGES Meetings
Friday, April 1, 2011 - 7:44am | 107Piper Jaffray has issued a report on the takeaways from the SAGES industry meeting in regards to C.R. Bard (NYSE: BCR). According to the report, "Discussions with BCR management at the SAGES industry meeting support our projections for above market growth for the Surgical Specialties division in...
-
Piper Jaffray Reiterates COV Overweight Rating
Friday, April 1, 2011 - 7:39am | 90Piper Jaffray has issued a report reiterating the Overweight Rating on Covidien (NYSE: COV). According to Piper Jaffray, "Medical devices represent ~70% of COV revenues and over 80% of earnings. The key sub-segments of endomechanical and energy comprise almost half of medical device revenues. Our...
-
Jefferies Initiates BCR At Buy
Friday, April 1, 2011 - 7:28am | 99Jefferies has initiated coverage of C.R. Bard (NYSE: BCR) at Buy. According to Jefferies, "BCR continues to execute soundly in the face of persistent and challenging headwinds and we see the top-end of 2011 guidance as achievable. BCR is well-managed, diverse in products, generates solid FCF and...
-
Morgan Keegan Updates On COV Following SAGES Meeting
Friday, April 1, 2011 - 7:23am | 109Morgan Keegan has issued a report on Covidien (NYSE: COV) following a meeting of the Society of American Gastrointestinal and Endoscopic Surgeons. According to the report, "Our take away from the meeting was (1) Covidien continues to innovate and improve its medical device franchise by introducing...
-
Jefferies Opens BCR With Buy
Friday, April 1, 2011 - 5:48am | 51Analysts at Jefferies initiate coverage of C.R. Bard Inc (NYSE: BCR) with a “buy” rating. The target price for BCR is set to $115. BCR shares gained 0.83% to close at $99.36 yesterday. More Analyst Ratings here
-
MAKO Surgical Corp. Up Nearly 14% (MAKO)
Thursday, March 31, 2011 - 3:32pm | 68MAKO Surgical Corp. (NASDAQ: MAKO) shares are soaring, up $2.94 to $24.38, a gain of 13.7% after the company announced yesterday it had received an order for 11 orthopedic knee surgery systems from Health Management Associates Inc. MAKO Surgical Corp., a medical device company, markets its...
-
Benzinga's Volume Movers (TSLA, DNDN, ACXM, MAKO)
Thursday, March 31, 2011 - 10:11am | 197Tesla Motors Inc (NASDAQ: TSLA) shares moved up 16.70% to $27.67 at 10:10 am. The volume of TSLA shares traded was 525% higher than normal. TSLA reported that electric Roadsters in more than 30 countries have now covered more than 10 million real-world miles. Dendreon Corporation (NASDAQ: DNDN)...